Curative Biotechnology, Inc. Share Price
Equities
CUBT
US23128N1081
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.027 USD | -3.57% | +10.66% | +26.76% |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
Sales 2020 | - | Sales 2021 | - | Capitalization | 29.41M 2.45B |
---|---|---|---|---|---|
Net income 2020 | -4M -334M | Net income 2021 | -5M -417M | EV / Sales 2020 | - |
Net Debt 2020 | 399K 33.3M | Net cash position 2021 | 670K 55.91M | EV / Sales 2021 | - |
P/E ratio 2020 |
-2.11
x | P/E ratio 2021 |
-1.44
x | Employees | 4 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 99.95% |
1 day | -3.57% | ||
1 week | +10.66% | ||
Current month | -3.57% | ||
1 month | -3.57% | ||
3 months | +8.00% | ||
6 months | +162.14% | ||
Current year | +26.76% |
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 11/21/11 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 12/22/12 |
Theresa Heah
BRD | Director/Board Member | 46 | 31/03 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
01/24/01 | 0.02 | -25.93% | 652,050 |
30/24/30 | 0.027 | -.--% | 64,175 |
29/24/29 | 0.027 | -3.57% | 75,915 |
26/24/26 | 0.028 | +11.11% | 5,000 |
25/24/25 | 0.0252 | -9.68% | 76,000 |
End-of-day quote OTC Markets, April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+26.76% | 18.07M | |
+23.39% | 42.68B | |
-3.00% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+8.11% | 24.94B | |
-19.85% | 18.96B | |
+29.71% | 12.3B | |
-3.30% | 11.95B | |
-2.33% | 11.55B |
- Stock Market
- Equities
- CUBT Stock